Mid Atlantic Bio Angels Portfolio Company, Cerus Endovascular, Receives CE Mark for Its Contour Neurovascular System™ for the ...
NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) -- Cerus Endovascular Ltd., one of Mid Atlantic Bio Angels’ (MABA) portfolio companies, recently announced receipt of CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment …